Analysis of niraparib-induced changes in glucose levels during three-month therapy in normoglycemic patients with ovarian cancer.
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2025.43.16_suppl.e17575
Abstract: e17575 Background: Poly(ADP-ribose) polymerase inhibitors (PARPis) are promising drugs for ovarian cancer (OC) patients, but their safety profile is still not well defined. In a previous study, the authors showed that olaparib-induced hyperglycaemia occurred in… read more here.
Keywords: therapy normoglycemic; therapy; analysis; three month ... See more keywords